http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
TOHO Cinemas And IMAX (IMAX) Expand Partnership With Six New IMAX With Laser Locations Across Japan
-
Clene (CLNN) Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
-
Recursion Pharmaceuticals (RXRX) Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas
-
22nd Century Group (XXII) CEO & Chairman Larry Firestone Provides Corporate Update Letter to Stockholders
-
Soluna Holdings (SLNH) Strengthens Texas Presence with New 120MW Wind-Powered Data Center Project
-
First-Ever AI Forecasting Avatar Released by Meteorologist Amy Freeze
-
Rallybio Corporation (RLYB) to Discontinue Development of RLYB212 for Prevention of FNAIT
-
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
-
Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas
-
22nd Century CEO & Chairman Larry Firestone Provides Corporate Update Letter to Stockholders
-
American Oncology Network Value-Based Care Director Anne Marie Rainey Appointed to ACCC Board of Trustees
-
TOHO Cinemas And IMAX® Expand Partnership With Six New IMAX With Laser Locations Across Japan
-
Hanover Bank Unveils a Refreshed Logo to Reflect Commitment to Innovation and Growth
-
Druva Expands FedRAMP Moderate Authorization, Launches New Cyber Resiliency Capabilities for Public Sector Organizations
-
AtriCure to Announce First Quarter 2025 Financial Results
-
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
-
Concentric AI Granted Patent for Its Innovative Approach to Identifying Users with Over-Permissioned Data Access
-
Soluna Strengthens Texas Presence with New 120MW Wind-Powered Data Center Project
-
22nd Century CEO & Chairman Larry Firestone Provides Corporate Update Letter to Stockholders
-
StorMagic Appoints Susan Odle as Chief Executive Officer to Accelerate Next Phase of Innovation and Growth
-
Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
-
True North Federal Credit Union Selects Mahalo Banking to Enhance Digital Security and Member Experience
-
XRPTurbo Launches $XRT Token On Bitmart, Set To Release Liquid Staking Platform & Upcoming Launchpad
-
XRPTurbo Launches $XRT Token On Bitmart, Set To Release Liquid Staking Platform & Upcoming Launchpad
-
ImmunityBio (IBRX) Announces Execution of $75 Million Equity Financing with an Institutional Investor
-
TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
-
Calamos Announces Upside Cap Rates for April Series of 100%, 90% and 80% Downside Protected Bitcoin ETFs Following Successful Launch of CBOA, CBXA and CBTA
-
ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor
-
DeFi Technologies Appoints Andrew Forson as President of DeFi Technologies and Chief Growth Officer of Valour
-
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
-
World’s Fastest Business Jet, the Bombardier Global 8000, in Final Assembly and Progressing on Schedule
-
CD&R Appoints Michael Harrington as Risk Director
-
OCTA WINS BEST CFD BROKER ASIA AWARD AT GLOBAL BRAND AWARDS 2025
-
Cartesian Therapeutics' (RNAC) Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial
-
New Jersey Resources Schedules Fiscal 2025 Second Quarter Earnings Call
-
PEPSICO® EXTENDS ITS PARTNERSHIP AS UEFA WOMEN'S FOOTBALL PARTNER THROUGH 2030
-
Walmart+ Goes All-In with Week of Exclusive Member Benefit Savings for Walmart+ Week
-
Cartesian Therapeutics’ Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial
-
Brainomix Advances Stroke Care with Landmark FDA Clearance
-
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
-
Sats Terminal Raises $1.7M to Simplify and Scale Bitcoin DeFi
-
Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET
-
The Big Financial Risk Most Seniors Are Not Prepared For
-
XRP News: XploraDEX Presale Gains Momentum as XRP’s First AI-Powered DEX Draws Investor Attention—Join $XPL Presale
-
DarrowEverett Acquires Saade Law to Further Boost South Florida Presence
-
Introducing the OmniCount™ Portable Water-Based Condensation Particle Counter
-
Riverbed Unveils Next-Generation AIOps, Adding Predictive, Agentic and Generative AI to the Riverbed Platform
-
Intelsat Installs Multi-Orbit System on 130 Aircraft, Nearing 1000 Orders
-
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
-
Hughes Completes Agreement with Airbus to Become Ka-band Managed Service Provider for HBCplus
